Figure 3From: Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency Treatment Outcome Score (TOS) in all HAE attacks with any abdominal symptoms treated with SC ecallantide. Includes all patients treated with 30 mg SC ecallantide in EDEMA2, EDEMA3, EDEMA4, and DX-88/19 (N = 521 attacks in 149 patients); analysis excludes attacks with missing data.Back to article page